Alendronate combats skeletal side effects of antiandrogen therapyBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.334.7595.661-b (Published 29 March 2007) Cite this as: BMJ 2007;334:661
Antiandrogen therapy may be an effective treatment for prostate cancer, but it has a detrimental effect on bone mineral density, which leads to osteoporosis and fractures. Men using gonadotrophin releasing hormone agonists, antiandrogens, or both, should …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial